Blog

Category: Research & Development

Research & Development

Promising Preclinical Data for AUR-101 Presented at BioTechX Europe 2025

Auralys Therapeutics presented encouraging preclinical data for its lead candidate, AUR-101, at the prestigious BioTechX Europe 2025 conference, drawing attention from the global scientific and

1 June 2025 No Comments

Auralys Therapeutic

Our mission is to accelerate breakthrough therapies that improve patient outcomes, focusing on diseases with high unmet medical needs. With a world-class team of scientists, drug developers, and industry leaders, Auralys Therapeutics is committed to delivering transformative medicines to the world.

Useful Links

Our Services

AI-Powered Drug Discovery
Target Identification & Validation
Structure-Based Drug Design
High-Throughput Screening
Preclinical Development
Clinical Development
Precision Therapeutics
Regulatory & Commercialization Strategy

Get the latest updates on scientific breakthroughs, pipeline progress, and company news from Auralys Therapeutics — directly to your inbox.